C. Nessler-Menardi

发表

Peptide YY-2 (PYY2) and pancreatic polypeptide-2 (PPY2): species-specific evolution of novel members of the neuropeptide Y gene family.

H. Klocker, H. Herzog, B. Kofler, 2000, Genomics.

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

H. Klocker, G. Bartsch, M. Cronauer, 1999, British Journal of Cancer.

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal‐cell culture models

H. Klocker, G. Bartsch, I. Eder, 2000, The Prostate.

Mechanism of Androgen Receptor Activation and Possible Implications for Chemoprevention Trials

H. Klocker, G. Bartsch, I. Eder, 1999, European Urology.

Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic

H. Klocker, G. Bartsch, I. Eder, 2001, European Urology.

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.

G Bartsch, H. Klocker, G. Bartsch, 1999, Cancer research.

Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

H. Klocker, G. Bartsch, I. Eder, 2000, Cancer Gene Therapy.

Pathway in Prostate Cancer Cell Lines Kinase A Activator on the Mitogen-activated Protein Kinase Action of EGF , Insulin-like Growth Factor I , and a Protein Epidermal Growth Factor ( EGF ) Receptor Blockade Inhibits the Updated

H. Klocker, G. Bartsch, H. Grunicke, 1998 .

Epidermal Growth Factor ( EGF ) Receptor Blockade Inhibits the Action of EGF , Insulin-like Growth Factor I , and a Protein Kinase A Activator on the Mitogen-activated Protein Kinase Pathway in Prostate Cancer Cell Lines 1

H. Klocker, G. Bartsch, H. Grunicke, 1998 .